메뉴 건너뛰기




Volumn 23, Issue 13, 2009, Pages

Current management of primary cutaneous CD30+ T-cell lymphoproliferative disorders

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BEXAROTENE; CARMUSTINE; CHLORMETHINE; CORTICOSTEROID; CUTANEOUS LYMPHOCYTE ASSOCIATED ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPITHELIAL MEMBRANE ANTIGEN; ETOPOSIDE; GAMMA INTERFERON; GAMMA1B INTERFERON; IMIQUIMOD; INTERLEUKIN 12; METHOTREXATE; PENTOSTATIN; PREDNISONE; PSORALEN; RETINOID; STEROID; TETRACYCLINE; VINCRISTINE;

EID: 73449146020     PISSN: 08909091     EISSN: 08909091     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (44)

References (32)
  • 1
    • 0014231954 scopus 로고
    • Lymphomatoid papulosis: A continuing self-healing eruption, clinically benign-hematologically malignant
    • Macaulay WL: Lymphomatoid papulosis: a continuing self-healing eruption, clinically benign-hematologically malignant. Arch Dermatol 97:23-31, 1968.
    • (1968) Arch Dermatol , vol.97 , pp. 23-31
    • Macaulay, W.L.1
  • 2
    • 0345293277 scopus 로고    scopus 로고
    • CD30+ cutaneous lymphoproliferative disorders: The Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma
    • Liu HJL, Hoppe RT, Kohler S, et al: CD30+ cutaneous lymphoproliferative disorders: The Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. J Am Acad Dermatol 1049-1058, 2003.
    • (2003) J Am Acad Dermatol , vol.1049-1058
    • Liu, H.J.L.1    Hoppe, R.T.2    Kohler, S.3
  • 3
    • 0034660654 scopus 로고    scopus 로고
    • Primary and secondary cutaneous CD30+ lymphoproliferative disorders: Report from the Dutch Cutaneous Lymphoma group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment
    • Bekkenk MW, Geelen FAMJ, Vader PC, et al: Primary and secondary cutaneous CD30+ lymphoproliferative disorders: Report from the Dutch Cutaneous Lymphoma group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 95:3653-3661, 2000.
    • (2000) Blood , vol.95 , pp. 3653-3661
    • Bekkenk, M.W.1    Geelen, F.A.M.J.2    Vader, P.C.3
  • 4
    • 0033214851 scopus 로고    scopus 로고
    • Increased risk of lymphoid and non-lymphoid malignancies in patients with lymphomatoid papulosis
    • Wang HH, Myers T, Lach LJ, et al: Increased risk of lymphoid and non-lymphoid malignancies in patients with lymphomatoid papulosis. Cancer 86:1240-1245,1999.
    • (1999) Cancer , vol.86 , pp. 1240-1245
    • Wang, H.H.1    Myers, T.2    Lach, L.J.3
  • 5
    • 0027952678 scopus 로고
    • Primary Ki-1 positive anaplastic large-cell lymphoma: A distinct clinicopathologic entity
    • Kadin ME: Primary Ki-1 positive anaplastic large-cell lymphoma: A distinct clinicopathologic entity. Ann Oncol 5(suppl 1):25-30, 1994.
    • (1994) Ann Oncol , vol.5 , Issue.SUPPL. 1 , pp. 25-30
    • Kadin, M.E.1
  • 6
    • 38949085902 scopus 로고    scopus 로고
    • Prognostic factors in childhood anaplastic large cell lymphoma: Results of a large European intergroup study
    • Le Deley M-C, Reiter A, Williams D, et al: Prognostic factors in childhood anaplastic large cell lymphoma: Results of a large European intergroup study. Blood 111:1560-1566, 2008.
    • (2008) Blood , vol.111 , pp. 1560-1566
    • Le Deley, M.-C.1    Reiter, A.2    Williams, D.3
  • 7
    • 0027216775 scopus 로고
    • Differences in clinical behavior and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null-cell phenotype
    • De Bruin PC, Beljaards RC, van Heerde P, et al: Differences in clinical behavior and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null-cell phenotype. Histopathology 23:127-135, 1993.
    • (1993) Histopathology , vol.23 , pp. 127-135
    • De Bruin, P.C.1    Beljaards, R.C.2    van Heerde, P.3
  • 8
    • 18544383148 scopus 로고    scopus 로고
    • Polymorphism of the CD30 promoter microsatellite repressive element is associated with development of primary cutaneous lymphoproliferative disorders
    • Franchina M, Kadin ME, Abraham LW: Polymorphism of the CD30 promoter microsatellite repressive element is associated with development of primary cutaneous lymphoproliferative disorders. Cancer Epidemiol Biomarkers Prev 14:1322-1325, 2005.
    • (2005) Cancer Epidemiol Biomarkers Prev , vol.14 , pp. 1322-1325
    • Franchina, M.1    Kadin, M.E.2    Abraham, L.W.3
  • 10
    • 1842787079 scopus 로고    scopus 로고
    • CD30(+) cutaneous lymphoma in association with atopic eczema
    • Fletcher CL, Orchard GE, Hubbard V, et al: CD30(+) cutaneous lymphoma in association with atopic eczema. Arch Dermatol 140:449-454, 2004.
    • (2004) Arch Dermatol , vol.140 , pp. 449-454
    • Fletcher, C.L.1    Orchard, G.E.2    Hubbard, V.3
  • 11
    • 62549122477 scopus 로고    scopus 로고
    • Recurrent translocations involving the IRF4 locus in peripheral T-cell lymphomas
    • Feldman AL, Law M, Remstein ED, et al: Recurrent translocations involving the IRF4 locus in peripheral T-cell lymphomas. Leukemia 23:574-580, 2009.
    • (2009) Leukemia , vol.23 , pp. 574-580
    • Feldman, A.L.1    Law, M.2    Remstein, E.D.3
  • 12
    • 0026755732 scopus 로고    scopus 로고
    • Beljaards RC, Willemze R: The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas. Br J Dermatol 126:596,-602,1992.
    • Beljaards RC, Willemze R: The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas. Br J Dermatol 126:596,-602,1992.
  • 13
    • 0029987036 scopus 로고    scopus 로고
    • The same dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis
    • Chott A, Vonderheid EC, Olbricht S, et al: The same dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis. J Invest Dermatol 106:696-700,1996.
    • (1996) J Invest Dermatol , vol.106 , pp. 696-700
    • Chott, A.1    Vonderheid, E.C.2    Olbricht, S.3
  • 14
    • 0031695440 scopus 로고    scopus 로고
    • Lymphomatoid papulosis in association with mycosis fungoides: A study of 15 cases
    • Basarab T, Fraser-Andrews EA, Orchard G, et al: Lymphomatoid papulosis in association with mycosis fungoides: A study of 15 cases. Br J Dermatol 139:680-688, 1998.
    • (1998) Br J Dermatol , vol.139 , pp. 680-688
    • Basarab, T.1    Fraser-Andrews, E.A.2    Orchard, G.3
  • 15
    • 0026486401 scopus 로고
    • Epidemiology of lymphomatoid papulosis
    • Wang HH, Lach L, Kadin ME: Epidemiology of lymphomatoid papulosis. Cancer 70:2951-2957, 1992.
    • (1992) Cancer , vol.70 , pp. 2951-2957
    • Wang, H.H.1    Lach, L.2    Kadin, M.E.3
  • 16
    • 0033214851 scopus 로고    scopus 로고
    • Increased risk of lymphoid and non-lymphoid malignancies in patients with lymphomatoid papulosis
    • Wang HH, Myers T, Lach LJ, et al: Increased risk of lymphoid and non-lymphoid malignancies in patients with lymphomatoid papulosis. Cancer 86:1240-1245, 1999.
    • (1999) Cancer , vol.86 , pp. 1240-1245
    • Wang, H.H.1    Myers, T.2    Lach, L.J.3
  • 17
    • 0029938791 scopus 로고    scopus 로고
    • A dominant inhibitory mutant of the type II TGF- β receptor in the malignant progression of a cutaneous T-cell lymphoma
    • Knaus P, Lindemann D, De Coteau JF, et al: A dominant inhibitory mutant of the type II TGF- β receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol Cell Biol 16:3480-3489, 1996.
    • (1996) Mol Cell Biol , vol.16 , pp. 3480-3489
    • Knaus, P.1    Lindemann, D.2    De Coteau, J.F.3
  • 18
    • 0032878291 scopus 로고    scopus 로고
    • A deletion in the gene for transforming growth factor-beta type I receptor abolishes growth regulation by transforming growth factor-beta in a cutaneous T cell lymphoma
    • Schiemann WP, Pfeifer WM, Levi E, et al: A deletion in the gene for transforming growth factor-beta type I receptor abolishes growth regulation by transforming growth factor-beta in a cutaneous T cell lymphoma. Blood 94:2854-2861, 1999.
    • (1999) Blood , vol.94 , pp. 2854-2861
    • Schiemann, W.P.1    Pfeifer, W.M.2    Levi, E.3
  • 19
    • 0029913823 scopus 로고    scopus 로고
    • Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders
    • Vonderheid EC, Sajjadian A, Kadin ME: Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders. J Am Acad Dermatol 34:470-481, 1996.
    • (1996) J Am Acad Dermatol , vol.34 , pp. 470-481
    • Vonderheid, E.C.1    Sajjadian, A.2    Kadin, M.E.3
  • 21
    • 0029855951 scopus 로고    scopus 로고
    • Th2 cytokine mRNA expression in primary cutaneous CD30-postiive lymphoproliferative disorders: Successful treatment with recombinant interferon-gamma
    • Yagi H, Tokura Y, Furukawas F, et al: Th2 cytokine mRNA expression in primary cutaneous CD30-postiive lymphoproliferative disorders: Successful treatment with recombinant interferon-gamma. J Invest Dermatol 107:827-832, 1996.
    • (1996) J Invest Dermatol , vol.107 , pp. 827-832
    • Yagi, H.1    Tokura, Y.2    Furukawas, F.3
  • 22
    • 0034307060 scopus 로고    scopus 로고
    • Therapeutic use of interferon-alpha for lymphomatoid papulosis
    • Schmuth M, Topar G, Illersperger B, et al: Therapeutic use of interferon-alpha for lymphomatoid papulosis. Cancer 89:1603-1610, 2000.
    • (2000) Cancer , vol.89 , pp. 1603-1610
    • Schmuth, M.1    Topar, G.2    Illersperger, B.3
  • 23
    • 0037276018 scopus 로고    scopus 로고
    • Bexarotene is a new treatment option for lymphomatoid papulosis
    • Krathen RA, Ward S, Duvic M: Bexarotene is a new treatment option for lymphomatoid papulosis. Dermatology 206:142-147, 2003.
    • (2003) Dermatology , vol.206 , pp. 142-147
    • Krathen, R.A.1    Ward, S.2    Duvic, M.3
  • 24
    • 0033939507 scopus 로고    scopus 로고
    • Lymphomatoid papulosis and anaplastic large cell lymphomas of the skin
    • Drews R, Samel A, Kadin ME: Lymphomatoid papulosis and anaplastic large cell lymphomas of the skin. Semin Cutan Med Surg 19:109-117, 2000.
    • (2000) Semin Cutan Med Surg , vol.19 , pp. 109-117
    • Drews, R.1    Samel, A.2    Kadin, M.E.3
  • 25
    • 0027289296 scopus 로고
    • Spectrum of parimary cutaneous CD30 (Ki-1)- positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment
    • Willemze R, Beljaards RC: Spectrum of parimary cutaneous CD30 (Ki-1)- positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol 28:973-980,1993.
    • (1993) J Am Acad Dermatol , vol.28 , pp. 973-980
    • Willemze, R.1    Beljaards, R.C.2
  • 26
    • 0027400943 scopus 로고
    • Primary cutaneous CD30-positive large cell lymphoma: Definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients
    • Beljaards RC, Kaudewitz P, Berti E, et al: Primary cutaneous CD30-positive large cell lymphoma: Definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients. Cancer 71:2097-2104, 1993.
    • (1993) Cancer , vol.71 , pp. 2097-2104
    • Beljaards, R.C.1    Kaudewitz, P.2    Berti, E.3
  • 27
    • 0029036853 scopus 로고
    • CD30/Ki-1+ lymphoproliferative disorders of the skin: Clinicopathologic correlation and statistical analysis of 86 cases
    • Paulli M, Berti E, Rosso R, et al: CD30/Ki-1+ lymphoproliferative disorders of the skin: Clinicopathologic correlation and statistical analysis of 86 cases. J Clin Oncol 12:1343-1354, 1995.
    • (1995) J Clin Oncol , vol.12 , pp. 1343-1354
    • Paulli, M.1    Berti, E.2    Rosso, R.3
  • 28
    • 0031884013 scopus 로고    scopus 로고
    • Primary cutaneous large-cell lymphoma. Analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Groupe dEtude des Lymphomas de lAdulte
    • Brice R, Cazals D, Mounier N, et al: Primary cutaneous large-cell lymphoma. Analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Groupe dEtude des Lymphomas de lAdulte. Leukemia 12:213-219, 1998.
    • (1998) Leukemia , vol.12 , pp. 213-219
    • Brice, R.1    Cazals, D.2    Mounier, N.3
  • 29
    • 0026466162 scopus 로고
    • Oral etoposide in treatment of cutaneous T-cell lymphoma
    • Rijlaarsdam JU, Hijgens PC, Beljaards RC, et al: Oral etoposide in treatment of cutaneous T-cell lymphoma. Br J Dermatol 127:524-528,1992.
    • (1992) Br J Dermatol , vol.127 , pp. 524-528
    • Rijlaarsdam, J.U.1    Hijgens, P.C.2    Beljaards, R.C.3
  • 30
    • 3142655707 scopus 로고    scopus 로고
    • Primary cutaneous CD30+ T-cell lymphoma responsive to topical imiquimod (Aldara)
    • Didona B, Benucci R, Amerio P, et al. Primary cutaneous CD30+ T-cell lymphoma responsive to topical imiquimod (Aldara). Br J Dermatol 150:1198-201, 2004.
    • (2004) Br J Dermatol , vol.150 , pp. 1198-1201
    • Didona, B.1    Benucci, R.2    Amerio, P.3
  • 31
    • 70349662167 scopus 로고    scopus 로고
    • A phase II study of SGN-30 (anti-CD30 monoclonal antibody) in cutaneous anaplastic large cell lymphoma and related lymphoproliferative disorders
    • Duvic M, Reddy SA, Pinter-Brown L, et al: A phase II study of SGN-30 (anti-CD30 monoclonal antibody) in cutaneous anaplastic large cell lymphoma and related lymphoproliferative disorders. Clin Cancer Res 15:6217-6224, 2009.
    • (2009) Clin Cancer Res , vol.15 , pp. 6217-6224
    • Duvic, M.1    Reddy, S.A.2    Pinter-Brown, L.3
  • 32
    • 0028012062 scopus 로고
    • Prognostic factors in aggressive non-Hodgkins lymphoma: Who has high-risk disease?
    • Shipp MA: Prognostic factors in aggressive non-Hodgkins lymphoma: Who has high-risk disease? Blood 83:1165-1173, 1994.
    • (1994) Blood , vol.83 , pp. 1165-1173
    • Shipp, M.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.